Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Clin |
RCV002259582 | SCV002540145 | pathogenic | Phenylketonuria | 2022-06-12 | reviewed by expert panel | curation | The c.1056del (p.Glu353AsnfsTer47) frameshift variant in PAH is predicted to terminate at codon 400 in exon 12, and would not undergo nonsense mediated-decay. This variant was reported in 4 patients within a Spanish cohort with mild and classic PKU. A defect in the synthesis or regeneration pathways 6R-BH4 was ruled out by analyzing urinary pterin levels as well as by measuring the dihydropteridine reductase activity (PMID 27121329). The variant was identified in trans with 4 pathogenic variants: p.Ala403Val, p.Ile306Val, c.1066-11G>A and p.Glu280Lys (PMID 27121329). This variant is absent from gnomAD. In summary, this variant meets criteria to be classified as pathogenic for PAH. PAH-specific ACMG/AMP criteria applied: PVS1_strong, PM2, PM3 very strong, and PP4 moderate. |
De |
RCV000088730 | SCV000119312 | not provided | not provided | no assertion provided | not provided | ||
Centre de Biologie Pathologie Génétique, |
RCV001252101 | SCV001427850 | likely benign | Intellectual disability | 2019-01-01 | no assertion criteria provided | clinical testing |